/Investor DB

Medblue — 2021 Investments

1 investments dated 2021 · listed companies and verified rows first · show all

Sparta Biomedicalspartabiomedical.cominDec 2021

Sparta Biomedical develops chemically engineered cartilage implants built on its Hyalos hydrogel platform, including Karthyx, an MTP hemiarthroplasty device that combines the cartilage-mimicking hydrogel with a titanium fixation technology.

BiotechHealthtechMedical DevicesMadison, US

Dushyanth Surakanti(Executive Officer, Director)inKen Gall(Director)Dimitrios Angelis(Executive Officer, Director)Sean Fontenot(Director)

Co-investorsDuke Capital Partners

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.